Toll Free: 1-888-928-9744

HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2016

Published: Jun, 2016 | Pages: 46 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2016', provides an overview of the HanAll Biopharma Co., Ltd.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by HanAll Biopharma Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of HanAll Biopharma Co., Ltd.
- The report provides overview of HanAll Biopharma Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses HanAll Biopharma Co., Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features HanAll Biopharma Co., Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate HanAll Biopharma Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for HanAll Biopharma Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding HanAll Biopharma Co., Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 HanAll Biopharma Co., Ltd. Snapshot 6 HanAll Biopharma Co., Ltd. Overview 6 Key Information 6 Key Facts 6 HanAll Biopharma Co., Ltd. - Research and Development Overview 7 Key Therapeutic Areas 7 HanAll Biopharma Co., Ltd. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Combination Treatment Modalities 12 HanAll Biopharma Co., Ltd. - Pipeline Products Glance 13 HanAll Biopharma Co., Ltd. - Late Stage Pipeline Products 13 Pre-Registration Products/Combination Treatment Modalities 13 Phase III Products/Combination Treatment Modalities 14 HanAll Biopharma Co., Ltd. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Phase I Products/Combination Treatment Modalities 16 HanAll Biopharma Co., Ltd. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 HanAll Biopharma Co., Ltd. - Drug Profiles 18 (atorvastatin calcium + losartan potassium) 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 (amlodipine besylate + candesartan cilexetil) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 (chlorthalidone + telmisartan) 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 cobamamide 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 HL-143 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 (candesartan cilexetil + metformin hydrochloride) 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 HL-036 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 somatropin 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 HL-156FIB 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 HL-161 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 HL-176 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 HL-178 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 HL-271 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 HanAll Biopharma Co., Ltd. - Pipeline Analysis 32 HanAll Biopharma Co., Ltd. - Pipeline Products by Target 32 HanAll Biopharma Co., Ltd. - Pipeline Products by Route of Administration 34 HanAll Biopharma Co., Ltd. - Pipeline Products by Molecule Type 35 HanAll Biopharma Co., Ltd. - Pipeline Products by Mechanism of Action 36 HanAll Biopharma Co., Ltd. - Recent Pipeline Updates 38 HanAll Biopharma Co., Ltd. - Dormant Projects 40 HanAll Biopharma Co., Ltd. - Discontinued Pipeline Products 43 Discontinued Pipeline Product Profiles 43 HL-015 43 HL-016 43 Loratadine ODT 43 HanAll Biopharma Co., Ltd. - Locations And Subsidiaries 44 Head Office 44 Other Locations & Subsidiaries 44 Appendix 45 Methodology 45 Coverage 45 Secondary Research 45 Primary Research 45 Expert Panel Validation 45 Contact Us 45 Disclaimer 46
List of Tables
HanAll Biopharma Co., Ltd., Key Information 6 HanAll Biopharma Co., Ltd., Key Facts 6 HanAll Biopharma Co., Ltd. - Pipeline by Indication, 2016 8 HanAll Biopharma Co., Ltd. - Pipeline by Stage of Development, 2016 10 HanAll Biopharma Co., Ltd. - Monotherapy Products in Pipeline, 2016 11 HanAll Biopharma Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016 12 HanAll Biopharma Co., Ltd. - Pre-Registration, 2016 13 HanAll Biopharma Co., Ltd. - Phase III, 2016 14 HanAll Biopharma Co., Ltd. - Phase II, 2016 15 HanAll Biopharma Co., Ltd. - Phase I, 2016 16 HanAll Biopharma Co., Ltd. - Preclinical, 2016 17 HanAll Biopharma Co., Ltd. - Pipeline by Target, 2016 32 HanAll Biopharma Co., Ltd. - Pipeline by Route of Administration, 2016 34 HanAll Biopharma Co., Ltd. - Pipeline by Molecule Type, 2016 35 HanAll Biopharma Co., Ltd. - Pipeline Products by Mechanism of Action, 2016 36 HanAll Biopharma Co., Ltd. - Recent Pipeline Updates, 2016 38 HanAll Biopharma Co., Ltd. - Dormant Developmental Projects,2016 40 HanAll Biopharma Co., Ltd. - Discontinued Pipeline Products, 2016 43 HanAll Biopharma Co., Ltd., Other Locations 44



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify